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FIGURE 1. B-type natriuretic peptide (BNP) level time course in the whole population and in neo-
nates according to disease severity. A, Values overall in Aristotle categories I, II, and III. B, Values
overall in Aristotle category IV. C, Values in neonates in Aristotle categories II and III. D, Values
in neonates in Aristotle category IV. Bold horizontal line represents median; box represents interquar-
tile range. At each time point, asterisk indicates P<.001 for difference from presurgery level; dagger
indicates P<.05 for difference from presurgery level; double dagger indicates P<.001 for difference
between neonates and older age group (infants, toddlers, and children); section mark indicates P<.05
for difference between neonates and older age group (infants, toddlers, and children).
LETTERS TO THE EDITORAGE- AND DISEASE-RELATED
VARIATIONS IN B-TYPE
NATRIURETIC PEPTIDE
RESPONSE AFTER PEDIATRIC
CARDIAC SURGERY
To the Editor:
We read with interest the article of
Amirnovin and colleagues,1 ‘‘B-type
natriuretic peptide levels predict out-
comes in infants undergoing cardiac
surgery in a lesion-dependent fash-
ion,’’ recently published in the Jour-
nal. We appreciate and agree with
the message of this work regarding
the importance of B-type natriuretic
peptide (BNP) as a prognostic marker
in pediatric cardiac surgery.
The opposing patterns of BNP post-
surgical response in the neonatal group
(postsurgical drop) and older children
(postoperative rise) are similar to those
we described in a recent work involv-
ing 162 children undergoing cardiac
surgery, including 57 neonates and
58 infants.2 We consider important
the division of patients by age and dis-
ease severity groups, with a particular
attention to the neonatal age, because
neonatal cardiac surgery carries on av-
erage a higher surgical risk and a more
troublesome outcome.2-4
Certainly, disease severity plays an
essential role in outcome and BNP
response, and this may justify division
by surgical intervention, such as
that suggested by Amirnovin and
colleagues.1At the same time, however,
age per se continues to represent an im-
portant additional, independent factor
affecting prognosis.2 In our own work,
both age and severity of diseaseThe Editor welcomes submissions for possible publica-
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The Journalindependently affected BNP levels in
children with congenital heart disease;
when age and disease severity were
considered together, however, only
age remained significant.2 Thus for the
same disease severity class age plays
an important role in hormonal response
(and in thefinal outcome). For example,
BNP levels in neonates with Aristotle
Basic Complexity (ABC) scores II and
II clearly differed from those in older
children with the same ABC scores
but did not differ from those in neonates
with ABC score IV (Figure 1).2
In particular, it is important to con-
sider how important maturational and
adaptive changes in cardiac function
(including cardiac endocrine func-
tion) occur early in life,2,5 which
may strongly affect BNP response in
neonates and infants with congenital
heart disease. A perfect system of
dividing children with congenital heartof Thoracic and Cardiovascular Surgerdisease undergoing cardiac surgery
(by age, by intervention, by disease) is
probably not easily achieved. Wider
studies, which may allow a robust
single-defect statistical analysis, are re-
quired to draw stronger conclusions. In
the meantime, age and disease should
be equally considered for correct
evaluation of BNP values in children
undergoing cardiac surgery.
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We appreciate the thoughtful com-
ments that Cantinotti and colleagues
expressed in their letter. Cantinotti
and colleagues are to be commended
for their important body ofwork,which
has advanced the understanding of
B-type natriuretic peptide (BNP) levels
in pediatric patients with congenital
heart disease.1
We agree that levels of BNP are age
dependent both in healthy neonates and
in those with congenital heart disease.
Also, as we indicated in the recent
article under discussion,2 the rapid
changes in BNP levels after surgical in-
tervention (within hours of the opera-
tion) imply that there are physiologic
changes associated with the specific
surgical interventions because of the
particular underlying cardiac defects
that determine the release of BNP.
Indeed, neonates with univentricular
physiology havevery highpreoperative
BNP levels relative to those of age-
matched healthy neonates and also rel-
ative to those with left-to-right shunts.
In our study, there was also a trend to-
ward higher BNP levels in neonates
with univentricular physiology relative
to those undergoing an arterial switch
operation.We believe this is one reason
that studies grouping neonates into sin-
gle cohorts,3,4 without consideration1416 The Journal of Thoracic andfor the specific cardiac defects, have
not found the postoperative decreases
in BNP that both we2 and Cantinotti
and colleagues1 found.
We therefore caution against relying
on disease severity scoring systems that
group diverse cardiac defects within
particular categories or combine vari-
ous diagnostic criteria, such as the
Risk Adjustment for Congenital Heart
Surgery 1 and Aristotle Basic Com-
plexity scores, for the interpretation of
perioperative BNP levels. Indeed, these
scoring systemsdonot fully account for
the variability in outcomes seen, dem-
onstrating that other factors remain
important.5 In attempting to understand
better the physiologic release of a bio-
marker and its implications for prog-
nostication and goal-directed therapy,
the use of such scoring systems is there-
fore likely to fall short in accounting for
the variability in levels of the bio-
marker. In fact, in Figure 1 of the letter
of Cantinotti and colleagues, neonates
in Aristotle Basic Complexity cate-
gories II and III can be seen to have
more variability in BNP levels than
those in category IV, probably because
of the differences in cardiac lesions and
the physiologic changes associated
with surgery that inherently differ by
category in these systems.A further ex-
ample of the specificitywe described in
our study was shown in preliminary
data from our previous work, where
we found that preoperative BNP level
in patients undergoing a total cavopul-
monary connection (Fontan procedure)
was the only significant predictor of
adverse postoperative outcomes.6
There is clearly much to learn about
the mechanisms involved in BNP re-
lease in patients with congenital heart
disease and the utility of this biomarker
in this population. We agree with Can-
tinotti and colleagues that further inves-
tigations into BNP changes during the
perioperative period are warranted.
On the basis of our combined data to
date, we believe that fully understand-
ing and interpreting perioperative
BNP changes will require accounting
for age, the cardiac lesion, and theCardiovascular Surgery c May 2013intervention that is undertaken. We
thank both the Editor and Cantinotti
and colleagues for this opportunity to
highlight this important topic.
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MYTH OR FACT?
To the Editor:
We read with great interest the arti-
cle entitled, ‘‘Tracheal regeneration:
Evidence of bone marrow mesenchy-
mal stem cell involvement,’’ by
Seguin and coworkers.1 We congratu-
late Seguin and coworkers1 for their
convincingdemonstration ofbonemar-
row–derived stem cell migration to the
grafted area after tracheal replacement
